Studies have shown that lagundi, a herbal remedy for cough and asthma, may alleviate mild Covid-19 symptoms provided it is taken correctly, according to the project leader of the clinical trials.
From July 2020 to August 2021, a two-stage, randomized double-blind, placebo-controlled research was undertaken on lagundi as alternative treatment.
Dr. Cecilia Maramba-Lazarte, who led the trials conducted by the University of the Philippines Manila and supported by the Department of Science and Technology (DoST)-Philippine Council for Health Research and Development, said adults may take the 600-milligram (mg) tablet or 5 milliliters (ml) of the 600 mg syrup thrice daily.
However, dosage requirements for pediatric patients may vary depending on their age.
In a recorded report aired Friday afternoon, DoST Secretary Fortunato de la Peña said the prescribed dosages will ensure that therapy with lagundi will yield beneficial results.
According to De la Peña, 300 mg syrup may be taken thrice daily by children, following the suggested dosage per intake: 2.5 to 5 ml for ages 2 to 4; 5 ml for ages 4 to 6; and 7.5 to 10 ml for ages 6 to 12.
He added that people 12 and above may also take 600 mg tablets thrice daily.
Clinical trials on lagundi as alternative treatment are designed to determine if the herb may provide symptomatic relief for mild Covid-19 patients without comorbidities, or if it can slow the progression of mild to moderate or severe cases.